Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amanda Herrmann

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Physical Therapy|November 23, 2013
Assessing proprioceptive function: evaluating joint position matching methods against psychophysical thresholdsNaveen Elangovan, Amanda Herrmann, Jürgen Konczak
Translational Cancer Research|January 9, 2026
Targeting MET in advanced and metastatic non-small cell lung cancer: a literature review of the current landscapeAmanda Herrmann, Christopher Grant, Lyudmila Bazhenova
Expert Opinion on Pharmacotherapy|July 23, 2025
Profiling opnurasib (JDQ-443) for the treatment of non-small cell lung cancer (NSCLC)Amanda Herrmann, Tali Azenkot, Van Hilburn, et al.
Clinical Lung Cancer|July 28, 2022
Evaluating Real World Mutational Differences Between Hispanics and Asians in NSCLC at a Large Academic Institution in Los AngelesRobert Hsu, Amanda Herrmann, Kush Gaur, et al.
ACG Case Reports Journal|January 16, 2019
Vanishing Bile Duct Syndrome in a Patient with Uterine Cancer and Paraneoplastic Systemic SclerosisDaniel Sedhom, Amanda Herrmann, Melroy D'Souza, et al.
Dermatology Practical & Conceptual|November 5, 2020
Validation of a Novel Cutaneous Neoplasm Diagnostic Self-Efficacy Instrument (CNDSEI) for Evaluating User-Perceived Confidence With DermoscopyKelly C Nelson, Ashley E Brown, Amanda Herrmann, et al.
The American Journal of Case Reports|March 22, 2026
Therapeutic Plasma Exchange for Uncontrollable Bleeding After Platelet Inhibition with Ticagrelor: A Report of 2 CasesAmanda Herrmann, Brenda Mai, Yu Bai, et al.
Lung Cancer (Amsterdam, Netherlands)|September 16, 2025
Clinical factors and molecular co-alterations impact outcomes in patients receiving first-line osimertinib for EGFR-mutated non-small cell lung cancerFangdi Sun, Mandeep K Banwait, Surbhi Singhal, et al.
Pharmacoepidemiology and Drug Safety|November 25, 2024
Determining Line of Therapy from Real-World Data in Non-Small Cell Lung CancerConnor B Grady, Wei-Ting Hwang, Joshua E Reuss, et al.
JTO Clinical and Research Reports|August 19, 2024
Characteristics of Long-Term Survivors With EGFR-Mutant Metastatic NSCLCWilliam Tompkins, Connor B Grady, Wei-Ting Hwang, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Physical Therapy|November 23, 2013
Assessing proprioceptive function: evaluating joint position matching methods against psychophysical thresholdsNaveen Elangovan, Amanda Herrmann, Jürgen Konczak
Translational Cancer Research|January 9, 2026
Targeting MET in advanced and metastatic non-small cell lung cancer: a literature review of the current landscapeAmanda Herrmann, Christopher Grant, Lyudmila Bazhenova
Expert Opinion on Pharmacotherapy|July 23, 2025
Profiling opnurasib (JDQ-443) for the treatment of non-small cell lung cancer (NSCLC)Amanda Herrmann, Tali Azenkot, Van Hilburn, et al.
Clinical Lung Cancer|July 28, 2022
Evaluating Real World Mutational Differences Between Hispanics and Asians in NSCLC at a Large Academic Institution in Los AngelesRobert Hsu, Amanda Herrmann, Kush Gaur, et al.
ACG Case Reports Journal|January 16, 2019
Vanishing Bile Duct Syndrome in a Patient with Uterine Cancer and Paraneoplastic Systemic SclerosisDaniel Sedhom, Amanda Herrmann, Melroy D'Souza, et al.
Dermatology Practical & Conceptual|November 5, 2020
Validation of a Novel Cutaneous Neoplasm Diagnostic Self-Efficacy Instrument (CNDSEI) for Evaluating User-Perceived Confidence With DermoscopyKelly C Nelson, Ashley E Brown, Amanda Herrmann, et al.
The American Journal of Case Reports|March 22, 2026
Therapeutic Plasma Exchange for Uncontrollable Bleeding After Platelet Inhibition with Ticagrelor: A Report of 2 CasesAmanda Herrmann, Brenda Mai, Yu Bai, et al.
Lung Cancer (Amsterdam, Netherlands)|September 16, 2025
Clinical factors and molecular co-alterations impact outcomes in patients receiving first-line osimertinib for EGFR-mutated non-small cell lung cancerFangdi Sun, Mandeep K Banwait, Surbhi Singhal, et al.
Pharmacoepidemiology and Drug Safety|November 25, 2024
Determining Line of Therapy from Real-World Data in Non-Small Cell Lung CancerConnor B Grady, Wei-Ting Hwang, Joshua E Reuss, et al.
JTO Clinical and Research Reports|August 19, 2024
Characteristics of Long-Term Survivors With EGFR-Mutant Metastatic NSCLCWilliam Tompkins, Connor B Grady, Wei-Ting Hwang, et al.
Pageof 2